肿瘤浸润免疫细胞在接受新辅助治疗的 HER2 阴性乳腺癌中的临床相关性
Clinical Relevance of Tumour-Infiltrating Immune Cells in HER2-Negative Breast Cancer Treated with Neoadjuvant Therapy.
48.0分
★★★☆☆
站内排序·非疗效
FRONTIER PAPERS
Clinical Relevance of Tumour-Infiltrating Immune Cells in HER2-Negative Breast Cancer Treated with Neoadjuvant Therapy.
Lymphoma-derived extracellular vesicles inhibit CAR T cell function.
共 2 条
MEMBER ACCOUNT
登录成功会直接打开下一页。